BioAge Labs (BIOA) Research & Development (2023 - 2026)
BioAge Labs (BIOA) posted Research & Development of $20.4 million for Q1 2026, down 16.69% sequentially from $24.5 million in Q4 2025, and up 83.72% YoY from $11.1 million in Q1 2025.
BioAge Labs (BIOA) Research & Development (2023 - 2026) Analysis & Trends
BioAge Labs has reported Research & Development for 4 years, with the latest figure at $20.4 million in Q1 2026.
- Quarterly Research & Development rose 83.72% year-over-year to $20.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.3 million (up 36.9% YoY) and the FY2025 annual result came in at $74.0 million, up 25.29% from the prior year.
- Research & Development fell to $20.4 million in Q1 2026 per BIOA's latest filing, from $24.5 million in the prior quarter.
- Over five years, Research & Development peaked at $24.5 million in Q4 2025 and troughed at $6.5 million in Q3 2023.
- A 4-year average of $15.5 million and a median of $18.5 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development soared 206.48% in 2024, then declined 7.52% in 2025.
- Over 4 years, Research & Development stood at $10.1 million in 2023, then soared by 90.69% to $19.2 million in 2024, then rose by 27.44% to $24.5 million in 2025, then declined by 16.69% to $20.4 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $20.4 million, $24.5 million, and $18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioAge Labs | 439.42 Mn | 439.42 Mn | -14.23 Mn | 24.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.37 Mn |
| Mar 31, 2026 | 20.41 Mn |
| Dec 31, 2025 | 24.50 Mn |
| Sep 30, 2025 | 18.51 Mn |
| Jun 30, 2025 | 19.84 Mn |
| Mar 31, 2025 | 11.11 Mn |
| Dec 31, 2024 | 19.23 Mn |
| Sep 30, 2024 | 20.02 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 9.32 Mn |
| Dec 31, 2023 | 10.08 Mn |
| Sep 30, 2023 | 6.53 Mn |